Search
for
Sort by
Research 91–120 of 410
- Dermatological adverse events with taxane chemotherapy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Drug-induced acne
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene
- Ginsenoside Rb1 promotes the growth of mink hair follicle via PI3K/AKT/GSK-3β signaling pathway
- Gender-Affirming Hormone Therapy for Transgender Men
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Changes of androgens levels in menopausal women
- Alopecia in Association with Malignancy: A Review
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Identifying the supportive care needs of men and women affected by chemotherapy-induced alopecia? A systematic review
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- MoS2 Nanoclusters-based biomaterials for disease- impaired wound therapy
- Alopecia-associated pseudocyst of the scalp
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Drug eruptions in dermatology
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Chemotherapy-Induced Hair Loss: The Use of Biomarkers for Predicting Alopecic Severity and Treatment Efficacy
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient